These observations hints that the embryonic reversal of cancer splicing drives cancer in conjunction with much broader transcription and epigenetic reprogramming mediated via perturbations in various master regulators (such as MYC and FOXM1) as well as critical splicing factors. This evidence concerns the gene MYC and cancer.